Skip to main content

Table 3 Quantitative coronary angiography analysis

From: Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis

 

Normal UA

Higher UA

p-value

Index PCI

n

257

71

 

Pre-procedural RVD (mm)

2.9 ± 0.4

3.0 ± 0.5

0.055

Pre-procedural MLD (mm)

0.6 ± 0.4

0.6 ± 0.4

0.396

Pre-procedural DS (mm)

79.0 ± 12.6

78.5 ± 12.4

0.749

Pre-procedural lesion length (mm)

20.1 ± 11.0

20.2 ± 10.2

0.959

Post-procedural MLD (mm)

2.7 ± 0.4

2.8 ± 0.6

0.105

Post-procedural DS (%)

8.6 ± 6.8

8.5 ± 11.9

0.925

Acute gain (mm)

2.1 ± 0.5

2.2 ± 0.6

0.293

Follow-up CAG

n

118

32

 

Median follow-up period (day)

462

527

0.559

Target lesion RVD (mm)

2.9 ± 0.5

2.9 ± 0.5

0.888

Target lesion MLD (mm)

1.9 ± 1.1

2.0 ± 1.1

0.590

Target lesion DS (%)

36.2 ± 34.2

33.4 ± 33.0

0.686

Late lumen loss (mm)

0.8 ± 1.1

0.8 ± 0.9

0.895

Binary restenosis, n (%)

41 (34.7)

9 (28.1)

0.622

  1. Data were presented as n (%) or mean ± SD. PCI, percutaneous coronary intervention; UA, uric acid; CAG, coronary angiography; RVD, reference vessel diameter; MLD, minimal lumen diameter; DS, diameter stenosis